Please find attached outcome of board meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunshield Chemicals' board approved audited financial results for Q4 and FY ended 31 March 2025, with auditors (CNK & Associates LLP) issuing an unmodified opinion. FY25 revenue from operations jumped to Rs. 36,579 lakhs from Rs. 28,338 lakhs in FY24, a growth of about 29%. However, profit for the year fell to Rs. 1,457 lakhs from Rs. 1,884 lakhs (down ~23%), and profit before tax dropped to Rs. 1,804 lakhs from Rs. 2,674 lakhs, indicating margin pressure as raw material costs rose sharply. The board recommended a final dividend of Rs. 2.5 per share (total payout ~Rs. 184 lakhs), subject to shareholder approval. Mr. Mukesh Malhotra was appointed as an Additional Independent Director for five years, and key board committees were reconstituted. The company's pending Rights Issue is awaiting SEBI clearance on certain deficiencies flagged in March 2025.
Mixed signals for shareholders: strong top-line growth is offset by a notable decline in profits and compressed margins, which may weigh on the stock in the short term. The dividend declaration and addition of a seasoned chemicals-industry director are positive, but investors should watch for margin recovery and resolution of the Rights Issue before drawing fresh conclusions.